Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol tartrate for rebound pain after brachial plexus block
ChiCTR2400081844Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butorphanol in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoints: Incidence of rebound pain and Quality of recovery. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
butorphanol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400081844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081844.